动态磁敏感对比增强MRI参数、ADC值及T2-FLAIR不匹配征有助于鉴别H3突变型与H3野生型高级别中线胶质瘤
本研究为单中心回顾性研究,纳入20例DMG-A和17例DMG-W患者,比较DSC-MRI参数、ADC值及T2-FLAIR不匹配征。结果显示DMG-A组nrCBF和ncrCBV显著低于DMG-W组,nADCmax显著高于DMG-W组,T2-FLAIR不匹配征在DMG-A组更常见。联合应用nrCBF<1.11、nADCmax≥2.48及T2-FLAIR不匹配征中至少两项阳性时诊断准确性最高(0.81)。
要点
- DMG-A组nrCBF和ncrCBV显著低于DMG-W组(nrCBF中位数0.88 vs 1.47,p<0.001)。
- T2-FLAIR不匹配征在DMG-A组更常见(55.0% vs 5.9%,p=0.0017)。
- nrCBF<1.11、nADCmax≥2.48及T2-FLAIR不匹配征中至少两项阳性时诊断准确性达0.81。
核心结论
- DSC-MRI参数、ADC值及T2-FLAIR不匹配征有助于鉴别DMG-A与DMG-W。
研究设计与样本
- 单中心回顾性研究,检索2015年6月至2021年5月电子数据库,纳入20例DMG-A(中位年龄13岁,范围3-52岁,女性11例)和17例DMG-W(中位年龄40岁,范围7-73岁,女性9例),比较DSC-MRI参数、ADC值及T2-FLAIR不匹配征。
关键影像表现/征象
- DMG-A组nrCBF中位数0.88(范围0.19-2.67)显著低于DMG-W组1.47(范围0.57-4.90),p<0.001。
- DMG-A组ncrCBV中位数1.17(范围0.20-2.67)显著低于DMG-W组1.56(范围0.60-4.03),p=0.008。
- DMG-A组nADCmax中位数2.37(范围1.25-3.98)显著高于DMG-W组1.95(范围1.23-2.77),p=0.02。
- T2-FLAIR不匹配征在DMG-A组11/20(55.0%)中阳性,显著高于DMG-W组1/17(5.9%),p=0.0017。
诊断标准与关键数值
- nrCBF<1.11、nADCmax≥2.48及T2-FLAIR不匹配征中至少两项阳性时诊断准确性最高,为0.81。
- nADCmax最佳截断值为2.48(原文报告nADCmax≥2.48为联合指标之一)。
临床应用与阅片要点
- 联合应用DSC-MRI参数(nrCBF、ncrCBV)、ADC值及T2-FLAIR不匹配征可辅助鉴别DMG-A与DMG-W。
- T2-FLAIR不匹配征在DMG-A中更常见,提示H3K27突变可能。
局限性
- 单中心回顾性研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Diffuse midline gliomas, H3K27-altered (DMG-A), are malignant gliomas with an unfavorable prognosis. Knowledge of dynamic susceptibility contrast (DSC) MRI findings and imaging differences with high-grade midline glioma without H3K27 alteration (DMG-W) has been limited. We compared the DSC, ADC, and conventional MRI findings between DMG-A and DMG-W.
METHODS: In this single institutional retrospective study, the electronic database of our hospital between June 2015 and May 2021 was searched. Twenty and 17 patients with DMG-A (median, 13 years; range, 3-52 years; 11 females) and DMG-W (median, 40 years; 7-73 years; 9 females), respectively, were found. Normalized relative cerebral blood flow (nrCBF) and normalized corrected relative cerebral blood volume (ncrCBV); normalized maximum, mean, and minimum ADC values; and the prevalence of T2-FLAIR mismatch sign were compared between the two groups using Mann-Whitney U tests and Fisher's exact test.
RESULTS: The nrCBF and ncrCBV were significantly lower in DMG-A compared with DMG-W (nrCBF: median 0.88 [range, 0.19-2.67] vs. 1.47 [range, 0.57-4.90] (p < 0.001); ncrCBV: 1.17 [0.20-2.67] vs. 1.56 [0.60-4.03] (p = 0.008)). Normalized maximum ADC (nADCmax) was significantly higher in DMG-A (median 2.37 [1.25-3.98] vs. 1.95 [1.23-2.77], p = 0.02). T2-FLAIR mismatch sign was significantly more common in DMG-A (11/20 (55.0%) vs. 1/17 (5.9%), p = 0.0017). When at least two of nrCBF < 1.11, nADCmax ≥ 2.48, and T2-FLAIR mismatch sign were positive, the diagnostic performance was the highest with accuracy of 0.81.
CONCLUSION: DSC-MRI parameters, ADC values, and the T2-FLAIR mismatch sign are useful to differentiate between DMG-A and DMG-W.
KEY POINTS: • Diffuse midline glioma, H3K27-altered (DMG-A), showed a significantly lower normalized relative cerebral blood flow and volume compared with H3K27-wild-type counterparts (DMG-W). • T2-fluid-attenuated inversion recovery (FLAIR) mismatch sign was significantly more frequent in DMG-A compared to DMG-W. • Indicators that combined DSC parameters, ADC values, and T2-FLAIR mismatch sign, with or without age, are useful to distinguish the two tumors.
引用
- Kurokawa, Kurokawa, Baba, et al. Dynamic susceptibility contrast-MRI parameters, ADC values, and the T2-FLAIR mismatch sign are useful to differentiate between H3-mutant and H3-wild-type high-grade midline glioma. Eur Radiol. 2022. PMID: 35022811. doi:10.1007/s00330-021-08476-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。